United States Central Venous Catheters Market Outlook | Key Players, Product Types & Regional Insights

central venous catheters market size reached US$3.03Billion in 2024 from US$2.89Billionin 2023 and is expected to reach US$ 4.71Billion by 2033, growing at a CAGR of 5.1%during the forecast period 2025-2033.

DataM Intelligence has published a new research report on "Central Venous Catheters Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/central-venous-catheters-market?kb

Latest M&A Activity

Continuous expansion: The central venous catheter market is highly competitive with consolidation among leading medical device manufacturers. Major players such as Teleflex, B. Braun, BD (Becton Dickinson), Smith Medical, and Cook Medical have focused on expanding product portfolios by integrating antimicrobial coatings, digital health features, and advanced needle protection technologies through acquisitions and partnerships.​

Recent investments: Companies are also investing in R&D and scaling capacity, as seen with expansion announcements and vertical integration with material and sensor technology providers to accelerate innovation.

Key Players:

BD, Teleflex Incorporated, B. Braun SE, Cook Medical, Angio Dynamics, ICU Medical, Inc., Merit Medical Systems, and Vygon Group

Growth Forecast Projected:

The Global Central Venous Catheters Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Recent Regulatory and FDA Approvals

FDA Clearances (2024-2025):
B. Braun's Introcan Safety 2 Deep Access IV Catheter
Granted FDA 510(k) clearance (October 2024) for a new deep access intravenous catheter, which features passive needlestick protection and longer-dwell multi-access capability designed for difficult vascular access patients.​

Basis Medical's Seclusion Catheter

Received FDA 510(k) clearance (March 2025) for superficial vein reflux treatment (dual-balloon, segmental ablation system), expanding application beyond traditional thermal techniques.​

Becton Dickinson (BD) CentroVena Central Venous Catheter
Gained FDA 510(k) clearance (April 2025) for the CentroVena CVC and CentroVena One Insertion System, a triple-lumen, short-term catheter with optimized flow for infusion, nutrition, pressure monitoring, and power injection for imaging.

Research Process:

Both primary and secondary data sources have been used in the global Central Venous Catheters Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=central-venous-catheters-market?kb

Key Segments:

by Product Type: (Non-Tunneled Central Venous Catheters, Tunneled Central Venous Catheters, Peripherally Inserted Central Catheters, Implantable Ports, and Others)

by End-User: (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others)

Regulatory and Infection Prevention Developments:

The CDC updated CLABSI (central line-associated bloodstream infection) prevention guidelines for CVCs and reinforced infection control protocols, which affect product usage and hospital purchasing.​

EU and FDA regulatory environments remain rigorous, requiring robust clinical evidence, new materials safety, and real-world performance data for new CVC approvals.​

Technological advancements such as antimicrobial coatings, biocompatible materials, and sensor-embedded "smart catheters" are being reviewed and launched to meet these stricter standards.

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Central Venous Catheters producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Central Venous Catheters revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/central-venous-catheters-market?kb

FAQ's

Q1: How fast is the Central Venous Catheters Market growing?

A: The Market is on an impressive growth trajectory, expected to expand at a CAGR of 5.1% from 2025 to 2032

Q2: Which regions are dominating the Central Venous Catheters Market and which are fastest-growing?

A: The Asia Pacific region is the fastest-growing market for central venous catheters, expanding at a CAGR of 5.7% in 2024.

Additional Noteworthy Trends

The CVC segment is driving innovation in catheter kits with integrated pressure injectors, antimicrobial features, and digital health connectivity.

Market growth is propelled by rising demand for long-term IV therapy, cancer care, and critical care settings, with the market projected to exceed $3 billion in 2025.​

Increased transition to outpatient and home-based IV therapy further supports new launches and regulatory adaptation.

Have any Query? Talk to our Expert @ https://www.datamintelligence.com/enquiry/central-venous-catheters-market?kb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.